sábado, 13 de agosto de 2011

Success of uterus-preserving treatments for abnorm... [Am J Obstet Gynecol. 2011] - PubMed result

Am J Obstet Gynecol. 2011 Mar;204(3):272.e1-7.
Success of uterus-preserving treatments for abnormal uterine bleeding, chronic pelvic pain, and symptomatic fibroids: age and bridges to menopause.
Learman LA, Nakagawa S, Gregorich SE, Jackson RA, Jacoby A, Kuppermann M.
Department of Obstetrics and Gynecology, Indiana University School of Medicine, Indianapolis, IN 46202, USA
. llearman@iupui.edu

OBJECTIVE: The purpose of this study was to determine whether age at first uterus-preserving treatment (UPT) predicts symptom resolution among women with common pelvic problems.

STUDY DESIGN: We conducted an analysis of 557 participants in the Study of Pelvic Problems, Hysterectomy and Intervention Alternatives cohort who reported having undergone a UPT. We performed multivariable regression modeling age at first UPT, hysterectomy, menopause, and other covariates to predict symptom resolution.

RESULTS: Mean ± SD age at enrollment was 42.7 ± 4.7 years; mean follow-up time was 4.4 ± 2.7 years. Sixteen percent of the women underwent hysterectomy; 37% of the women entered menopause. Hysterectomy was a strong predictor of symptom resolution (P < .001). Compared with women who were younger (first UPT at age <40 years), older women reported greater symptom resolution, even after the data were controlled for hysterectomy use and menopausal status (P = .028).

CONCLUSION: Women who are ≥40 years old when they undergo their first uterus-preserving treatment experience greater symptom resolution than younger women. Framing UPTs as hysterectomy alternatives may be accurate only for a subset of women who are >40 years old.

Copyright © 2011 Mosby, Inc. All rights reserved.

PMID:21376169[PubMed - indexed for MEDLINE]
Success of uterus-preserving treatments for abnorm... [Am J Obstet Gynecol. 2011] - PubMed result

No hay comentarios: